AAAAAA
Results: 76-100/366
Authors:
LONDON SJ
SULLIVANKLOSE T
DALY AK
IDLE JR
Citation: Sj. London et al., LUNG-CANCER RISK IN RELATION TO THE CYP2C9 GENETIC-POLYMORPHISM AMONGCAUCASIANS IN LOS-ANGELES-COUNTY, Pharmacogenetics, 7(5), 1997, pp. 401-404
Authors:
NASU K
KUBOTA T
ISHIZAKI T
Citation: K. Nasu et al., GENETIC-ANALYSIS OF CYP2C9 POLYMORPHISM IN A JAPANESE POPULATION, Pharmacogenetics, 7(5), 1997, pp. 405-409
Authors:
BOUSTEAD C
TABER H
IDLE JR
CHOLERTON S
Citation: C. Boustead et al., CYP2D6 GENOTYPE AND SMOKING-BEHAVIOR IN CIGARETTE SMOKERS, Pharmacogenetics, 7(5), 1997, pp. 411-414
Authors:
SUZUKI A
OTANI K
MIHARA K
YASUI N
KANEKO S
INOUE Y
HAYASHI K
Citation: A. Suzuki et al., EFFECTS OF THE CYP2D6 GENOTYPE ON THE STEADY-STATE PLASMA-CONCENTRATIONS OF HALOPERIDOL AND REDUCED HALOPERIDOL IN JAPANESE SCHIZOPHRENIC-PATIENTS, Pharmacogenetics, 7(5), 1997, pp. 415-418
Authors:
WATANABE J
HARADA N
SUEMASU K
HIGASHI Y
GOTOH O
KAWAJIRI K
Citation: J. Watanabe et al., ARGININE-CYSTEINE POLYMORPHISM AT CODON-264 OF THE HUMAN CYP19 GENE DOES NOT AFFECT AROMATASE-ACTIVITY, Pharmacogenetics, 7(5), 1997, pp. 419-424
Authors:
SOHN DR
KWON JT
KIM HK
Citation: Dr. Sohn et al., THE GENETIC-POLYMORPHISM OF ANGIOTENSIN-CONVERTING ENZYME IN A KOREANPOPULATION, Pharmacogenetics, 7(5), 1997, pp. 425-427
Authors:
RADY JJ
FUJIMOTO JM
Citation: Jj. Rady et Jm. Fujimoto, ANALGESIC RESPONSE IN OFFSPRING OF CROSSES BETWEEN HEROIN DELTA-RESPONDING (SWISS WEBSTER) AND MU-RESPONDING (ICR) MICE, Pharmacogenetics, 7(5), 1997, pp. 429-433
Authors:
MACKENZIE PI
OWENS IS
BURCHELL B
BOCK KW
BAIROCH A
BELANGER A
FOURNELGIGLEUX S
GREEN M
HUM DW
IYANAGI T
LANCET D
LOUISOT P
MAGDALOU J
CHOWDHURY JR
RITTER JK
SCHACHTER H
TEPHLY TR
TIPTON KF
NEBERT DW
Citation: Pi. Mackenzie et al., THE UDP GLYCOSYLTRANSFERASE GENE SUPERFAMILY - RECOMMENDED NOMENCLATURE UPDATE BASED ON EVOLUTIONARY DIVERGENCE, Pharmacogenetics, 7(4), 1997, pp. 255-269
Authors:
FINCKH U
ROMMELSPACHER H
KUHN S
DUFEU P
OTTO G
HEINZ A
DETTLING M
GIRALDOVELASQUEZ M
PELZ J
GRAF KJ
HARMS H
SANDER T
SCHMIDT LG
ROLFS A
Citation: U. Finckh et al., INFLUENCE OF THE DOPAMINE D2 RECEPTOR (DRD2) GENOTYPE ON NEUROADAPTIVE EFFECTS OF ALCOHOL AND THE CLINICAL OUTCOME OF ALCOHOLISM, Pharmacogenetics, 7(4), 1997, pp. 271-281
Authors:
CASLEY WL
MENZIES JA
MOUSSEAU N
GIRARD M
MOON TW
WHITEHOUSE LW
Citation: Wl. Casley et al., INCREASED BASAL EXPRESSION OF HEPATIC CYP1A1 AND CYP1A2 GENES IN INBRED MICE SELECTED FOR SUSCEPTIBILITY TO ACETAMINOPHEN-INDUCED HEPATOTOXICITY, Pharmacogenetics, 7(4), 1997, pp. 283-293
Authors:
KIVISTO KT
GRIESE KU
STUVEN T
FRITZ P
FRIEDEL G
KROEMER HK
ZANGER UM
Citation: Kt. Kivisto et al., ANALYSIS OF CYP2D6 EXPRESSION IN HUMAN LUNG - IMPLICATIONS FOR THE ASSOCIATION BETWEEN CYP2D6 ACTIVITY AND SUSCEPTIBILITY TO LUNG-CANCER, Pharmacogenetics, 7(4), 1997, pp. 295-302
Authors:
MROZIKIEWICZ PM
CASCORBI I
BROCKMOLLER J
ROOTS I
Citation: Pm. Mrozikiewicz et al., CYP1A1 MUTATIONS 4887A, 4889G, 5639C AND 6235C IN THE POLISH POPULATION AND THEIR ALLELIC LINKAGE, DETERMINED BY PEPTIDE NUCLEIC ACID-MEDIATED PCR CLAMPING, Pharmacogenetics, 7(4), 1997, pp. 303-307
Authors:
HU JJ
ROUSH GC
DUBIN N
BERWICK M
ROSES DF
HARRIS MN
Citation: Jj. Hu et al., POLY(ADP-RIBOSE) POLYMERASE IN HUMAN BREAST-CANCER - A CASE-CONTROL ANALYSIS, Pharmacogenetics, 7(4), 1997, pp. 309-316
Authors:
LEVESQUE E
BEAULIEU M
GREEN MD
TEPHLY TR
BELANGER A
HUM DW
Citation: E. Levesque et al., ISOLATION AND CHARACTERIZATION OF UGT2B15(Y-85) - A UDP-GLUCURONOSYLTRANSFERASE ENCODED BY A POLYMORPHIC GENE, Pharmacogenetics, 7(4), 1997, pp. 317-325
Authors:
AYNACIOGLU AS
CASCORBI I
MROZIKIEWICZ PM
ROOTS I
Citation: As. Aynacioglu et al., ARYLAMINE N-ACETYLTRANSFERASE (NAT2) GENOTYPES IN A TURKISH POPULATION, Pharmacogenetics, 7(4), 1997, pp. 327-331
Authors:
RUAS JL
LECHNER MC
Citation: Jl. Ruas et Mc. Lechner, ALLELE FREQUENCY OF CYP2C19 IN A PORTUGUESE POPULATION, Pharmacogenetics, 7(4), 1997, pp. 333-335
Authors:
AGUNDEZ JAG
RAMIREZ R
HERNANDEZ M
LLERENA A
BENITEZ J
Citation: Jag. Agundez et al., MOLECULAR HETEROGENEITY AT THE CYP2D GENE LOCUS IN NICARAGUANS - IMPACT OF GENE-FLOW FROM EUROPE, Pharmacogenetics, 7(4), 1997, pp. 337-340
Authors:
ASADA M
GOTO H
ABE M
TACHIBANA T
SUZUKI Y
SUZUKI T
Citation: M. Asada et al., N-ACETYLATION POLYMORPHISM IN JAPANESE PATIENTS WITH SARCOIDOSIS, Pharmacogenetics, 7(4), 1997, pp. 341-344
Authors:
EKINS S
VANDENBRANDEN M
RING BJ
WRIGHTON SA
Citation: S. Ekins et al., EXAMINATION OF PURPORTED PROBES OF HUMAN CYP2B6, Pharmacogenetics, 7(3), 1997, pp. 165-179
Authors:
BELLOC C
GAUFFRE A
ANDRE C
BEAUNE PH
Citation: C. Belloc et al., EPITOPE MAPPING OF HUMAN CYP1A2 IN DIHYDRALAZINE-INDUCED AUTOIMMUNE HEPATITIS, Pharmacogenetics, 7(3), 1997, pp. 181-186
Authors:
MCLELLAN RA
OSCARSON M
SEIDEGARD J
EVANS DAP
INGELMANSUNDBERG M
Citation: Ra. Mclellan et al., FREQUENT OCCURRENCE OF CYP2D6 GENE DUPLICATION IN SAUDI-ARABIANS, Pharmacogenetics, 7(3), 1997, pp. 187-191
Authors:
MAREZ D
LEGRAND M
SABBAGH N
LOGUIDICE JM
SPIRE C
LAFITTE JJ
MEYER UA
BROLY F
Citation: D. Marez et al., POLYMORPHISM OF THE CYTOCHROME-P450 CYP2D6 GENE IN A EUROPEAN POPULATION - CHARACTERIZATION OF 48 MUTATIONS AND 53 ALLELES, THEIR FREQUENCIES AND EVOLUTION, Pharmacogenetics, 7(3), 1997, pp. 193-202
Authors:
CRESPI CL
MILLER VP
Citation: Cl. Crespi et Vp. Miller, THE R144C CHANGE IN THE CYP2C9-ASTERISK-2 ALLELE ALTERS INTERACTION OF THE CYTOCHROME-P450 WITH NADPH-CYTOCHROME P450 OXIDOREDUCTASE, Pharmacogenetics, 7(3), 1997, pp. 203-210
Authors:
CHANG TKH
YU L
GOLDSTEIN JA
WAXMAN DJ
Citation: Tkh. Chang et al., IDENTIFICATION OF THE POLYMORPHICALLY EXPRESSED CYP2C19 AND THE WILD-TYPE CYP2C9-ILE359 ALLELE AS LOW-K-M CATALYSTS OF CYCLOPHOSPHAMIDE ANDIFOSFAMIDE ACTIVATION, Pharmacogenetics, 7(3), 1997, pp. 211-221
Authors:
HE XX
NEBERT DW
VASILIOU V
ZHU H
SHERTZER HG
Citation: Xx. He et al., GENETIC-DIFFERENCES IN ALCOHOL-DRINKING PREFERENCE BETWEEN INBRED STRAINS OF MICE, Pharmacogenetics, 7(3), 1997, pp. 223-233